IDiyas

For the Inventor, By the Inventor

Osaka, Japan

Hideyuki Igawa

USPTO Granted Patents = 11 


 

Average Co-Inventor Count = 3.3

ph-index = 2

Forward Citations = 9(Granted Patents)


Location History:

  • Osaka, JP (2010 - 2015)
  • Kanagawa, JP (2015 - 2016)

Company Filing History:

goldMedal11 out of 1,177 
 
Takeda Pharmaceutical Company Limited
 patents

Years Active: 2010-2016

Loading Chart...
Loading Chart...
Loading Chart...
11 patents (USPTO):
1. 9505772 - Aromatic ring compound (2016-11-29),
2. 9440987 - Aromatic ring compound (2016-09-13),
3. 9365540 - Benzimidazole derivatives as MCH receptor antagonists (2016-06-14),
4. 9199963 - Heterocyclic compound (2015-12-01),
5. 9115136 - Fused ring compound and use thereof (2015-08-25),
6. 8921379 - Fused ring compound and use thereof (2014-12-30),
7. 8592431 - Fused ring compound and use thereof (2013-11-26),
8. 8501750 - Heterocyclic compound and use thereof (2013-08-06),
9. 8283353 - Fused ring compound and use thereof (2012-10-09),
10. 7998968 - Substituted pyrimidines and [1,2, 4] triazoles and the use thereof for treating prophylaxis, cardiovascular diseases, metabolic diseases and/or central nervous system diseases (2011-08-16),
11. 7803940 - Heteromonocyclic compound or a salt thereof having strong antihypertensive action, insulin sensitizing activity and the like production thereof and use thereof for prophylaxis or treatment of cardiovascular diseases, metabolic diseases and/or central nervous system diseases (2010-09-28),

Title: The Innovative Journey of Hideyuki Igawa: Pioneering Solutions in Pharmaceuticals

Introduction: Hideyuki Igawa, a prolific inventor based in Osaka, JP, has made significant contributions to the field of pharmaceuticals with his groundbreaking inventions. With 11 patents to his name, Igawa has been at the forefront of developing solutions for various health challenges.

Latest Patents: Igawa's latest patents encompass revolutionary aromatic ring compounds with melanin-concentrating hormone receptor antagonistic actions, designed to address obesity and related conditions. These compounds, represented by specific formulas outlined in the patent specifications, hold immense promise as prophylactic or therapeutic agents.

Career Highlights: Hideyuki Igawa is a valued member of the renowned Takeda Pharmaceutical Company Limited, a leading player in the global pharmaceutical industry. His expertise and dedication have been instrumental in driving forward innovative research and development initiatives within the company.

Collaborations: Igawa has collaborated closely with esteemed colleagues such as Tsuyoshi Maekawa and Minoru Yoshida, leveraging their collective expertise to push the boundaries of pharmaceutical innovation. Together, they have fostered a culture of excellence and ingenuity in their shared pursuit of novel solutions.

Conclusion: Hideyuki Igawa's inventive spirit and commitment to advancing pharmaceutical science have established him as a trailblazer in the field. His patents and collaborations stand as testaments to his unwavering pursuit of excellence and his enduring impact on the world of healthcare innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…